JP2023513124A5 - - Google Patents
Info
- Publication number
- JP2023513124A5 JP2023513124A5 JP2022547208A JP2022547208A JP2023513124A5 JP 2023513124 A5 JP2023513124 A5 JP 2023513124A5 JP 2022547208 A JP2022547208 A JP 2022547208A JP 2022547208 A JP2022547208 A JP 2022547208A JP 2023513124 A5 JP2023513124 A5 JP 2023513124A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- amino acid
- acid sequence
- seq
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025187155A JP2026027362A (ja) | 2020-02-10 | 2025-11-06 | 抗ｔｍｐｒｓｓ２抗体および抗原結合断片 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062972338P | 2020-02-10 | 2020-02-10 | |
| US62/972,338 | 2020-02-10 | ||
| US202063021016P | 2020-05-06 | 2020-05-06 | |
| US63/021,016 | 2020-05-06 | ||
| US202063094199P | 2020-10-20 | 2020-10-20 | |
| US63/094,199 | 2020-10-20 | ||
| PCT/US2021/017290 WO2021163076A1 (en) | 2020-02-10 | 2021-02-09 | ANTl-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025187155A Division JP2026027362A (ja) | 2020-02-10 | 2025-11-06 | 抗ｔｍｐｒｓｓ２抗体および抗原結合断片 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513124A JP2023513124A (ja) | 2023-03-30 |
| JP2023513124A5 true JP2023513124A5 (enExample) | 2024-02-14 |
| JP7772702B2 JP7772702B2 (ja) | 2025-11-18 |
Family
ID=74798119
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547208A Active JP7772702B2 (ja) | 2020-02-10 | 2021-02-09 | 抗ｔｍｐｒｓｓ２抗体および抗原結合断片 |
| JP2025187155A Pending JP2026027362A (ja) | 2020-02-10 | 2025-11-06 | 抗ｔｍｐｒｓｓ２抗体および抗原結合断片 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025187155A Pending JP2026027362A (ja) | 2020-02-10 | 2025-11-06 | 抗ｔｍｐｒｓｓ２抗体および抗原結合断片 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11999799B2 (enExample) |
| EP (1) | EP4103619A1 (enExample) |
| JP (2) | JP7772702B2 (enExample) |
| KR (1) | KR20220140503A (enExample) |
| CN (1) | CN115427457A (enExample) |
| AU (1) | AU2021219671A1 (enExample) |
| CA (1) | CA3163164A1 (enExample) |
| IL (1) | IL294529A (enExample) |
| MX (1) | MX2022009476A (enExample) |
| WO (1) | WO2021163076A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021219671A1 (en) * | 2020-02-10 | 2022-07-14 | Regeneron Pharmaceuticals, Inc. | Anti-Tmprss2 Antibodies and Antigen-Binding Fragments |
| US12133966B2 (en) | 2020-12-22 | 2024-11-05 | Regina E. HERZLINGER | Methods, systems, and apparatus for administering an antibody treatment via infusion |
| US20220193235A1 (en) * | 2020-12-22 | 2022-06-23 | Regina E. HERZLINGER | Methods, systems, and apparatus for administering a monoclonal and/or polyclonal antibody treatment via rapid infusion |
| US11806507B2 (en) | 2020-12-22 | 2023-11-07 | Regina E. HERZLINGER | Methods, systems, and apparatus for administering an antibody treatment via infusion |
| WO2023086989A1 (en) * | 2021-11-12 | 2023-05-19 | Adrx, Inc. | Transthyretin (ttr) monomer binding antibodies |
| JPWO2023199943A1 (enExample) * | 2022-04-12 | 2023-10-19 | ||
| CN116003611B (zh) * | 2022-08-17 | 2024-02-27 | 中南大学湘雅医院 | 抗tmprss2抗体及其用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
| US5693489A (en) | 1984-03-30 | 1997-12-02 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US4952496A (en) | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| DE60138465D1 (de) | 2000-07-12 | 2009-06-04 | Agensys Inc | Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| ATE537190T1 (de) | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| WO2008127347A1 (en) | 2006-07-21 | 2008-10-23 | Diadexus, Inc. | Pro115 antibody compositions and methods of use |
| JP2010500876A (ja) | 2006-08-18 | 2010-01-14 | アブリンクス エン．ヴェー． | Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド |
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| US9212226B2 (en) | 2008-05-16 | 2015-12-15 | Ablynx N.V. | Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same |
| EP2838558A1 (en) | 2012-04-16 | 2015-02-25 | Regeneron Pharmaceuticals, Inc. | Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor |
| US20150203591A1 (en) | 2012-08-02 | 2015-07-23 | Regeneron Pharmaceuticals, Inc. | Mutivalent antigen-binding proteins |
| TWI754319B (zh) * | 2014-03-19 | 2022-02-01 | 美商再生元醫藥公司 | 用於腫瘤治療之方法及抗體組成物 |
| JO3701B1 (ar) | 2014-05-23 | 2021-01-31 | Regeneron Pharma | مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| TWI701258B (zh) | 2014-12-19 | 2020-08-11 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| CN109068621B (zh) | 2016-02-29 | 2021-07-20 | 再生元制药公司 | 具有人源化的tmprss基因的啮齿类动物 |
| EP3638698B1 (en) * | 2018-01-26 | 2021-03-03 | Regeneron Pharmaceuticals, Inc. | Anti-tmprss2 antibodies and antigen-binding fragments |
| AU2021219671A1 (en) * | 2020-02-10 | 2022-07-14 | Regeneron Pharmaceuticals, Inc. | Anti-Tmprss2 Antibodies and Antigen-Binding Fragments |
-
2021
- 2021-02-09 AU AU2021219671A patent/AU2021219671A1/en active Pending
- 2021-02-09 CN CN202180013863.0A patent/CN115427457A/zh active Pending
- 2021-02-09 JP JP2022547208A patent/JP7772702B2/ja active Active
- 2021-02-09 US US17/171,941 patent/US11999799B2/en active Active
- 2021-02-09 IL IL294529A patent/IL294529A/en unknown
- 2021-02-09 WO PCT/US2021/017290 patent/WO2021163076A1/en not_active Ceased
- 2021-02-09 MX MX2022009476A patent/MX2022009476A/es unknown
- 2021-02-09 CA CA3163164A patent/CA3163164A1/en active Pending
- 2021-02-09 KR KR1020227026885A patent/KR20220140503A/ko active Pending
- 2021-02-09 EP EP21708898.8A patent/EP4103619A1/en active Pending
-
2024
- 2024-04-22 US US18/642,721 patent/US20240343831A1/en active Pending
-
2025
- 2025-11-06 JP JP2025187155A patent/JP2026027362A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL312961A (en) | Anti-tmprss2 antibodies and antigen-binding fragments | |
| JP2021511058A5 (enExample) | ||
| RU2755724C2 (ru) | Pd1/ctla4-связывающие вещества | |
| JP7754506B2 (ja) | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 | |
| EP2776468B1 (en) | Methods of inhibiting tumor growth by antagonizing il-6 receptor | |
| JP2021516973A5 (enExample) | ||
| TWI831789B (zh) | 二聚體及其用途 | |
| JP2024174962A (ja) | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 | |
| CN103536917B (zh) | 干扰素在治疗肿瘤中的用途及相关的产品和方法 | |
| CN102884081A (zh) | 用dll4拮抗剂治疗自身免疫疾病的方法 | |
| KR102399028B1 (ko) | 이중-특이적 항원-결합 폴리펩티드 | |
| JP2021063092A (ja) | Ｂ型肝炎表面抗原に対する抗体及びその使用 | |
| AU2019226551A1 (en) | Methods for altering body composition | |
| KR20230013125A (ko) | 4-1bb 결합 단백질 및 이의 용도 | |
| JP2022553908A (ja) | Ｐｄ１およびｖｅｇｆｒ２二重結合剤 | |
| WO2019078698A2 (ko) | 항 -msln항체 및 이를포함하는 암치료용 약학적 조성물 | |
| US20240082394A1 (en) | Combination therapy for the treatment of cancer | |
| CN116262790A (zh) | 嵌合的抗cd27抗体组合物及其应用 | |
| WO2023178253A2 (en) | Use of a multimeric anti-pd-l1 binding molecule in combination with a monoclonal antibody therapy | |
| CA3212850A1 (en) | Anti-egfrviii antibody drug conjugates and uses thereof | |
| TWI895253B (zh) | 抗平足蛋白抗體 | |
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| CN106963950B (zh) | 用于治疗肿瘤的联合用药物 | |
| JP6737482B1 (ja) | 抗ポドプラニン抗体 | |
| WO2024069240A2 (en) | Cd38-binding fusion protein combination therapy |